JD Health International Inc.
JDHIF
$6.27
$1.1722.95%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 6.83% | 3.13% | -1.73% | 3.39% | 9.28% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 6.83% | 3.13% | -1.73% | 3.39% | 9.28% |
Cost of Revenue | 5.87% | 2.15% | -2.72% | 2.24% | 7.90% |
Gross Profit | 10.20% | 6.62% | 1.83% | 7.58% | 14.42% |
SG&A Expenses | 6.43% | 4.56% | 1.37% | 3.72% | 6.30% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 5.99% | 2.65% | -1.88% | 2.58% | 7.63% |
Operating Income | 74.18% | 40.65% | 10.14% | 150.43% | 557.04% |
Income Before Tax | 73.78% | 62.42% | 47.51% | 101.76% | 269.11% |
Income Tax Expenses | 14.26% | 32.55% | 54.38% | 59.68% | 67.14% |
Earnings from Continuing Operations | 88.91% | 69.91% | 45.81% | 116.52% | 432.77% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | 555.05% | 231.83% | 153.29% | 117.61% | 66.58% |
Net Income | 89.22% | 70.33% | 46.31% | 117.34% | 436.64% |
EBIT | 74.18% | 40.65% | 10.14% | 150.43% | 557.04% |
EBITDA | 57.31% | 32.97% | 9.86% | 117.43% | 1,619.54% |
EPS Basic | 87.96% | 69.41% | 45.53% | 116.67% | 435.52% |
Normalized Basic EPS | 73.05% | 61.90% | 47.26% | 101.68% | 269.23% |
EPS Diluted | 90.05% | 71.87% | 48.33% | 119.25% | 436.11% |
Normalized Diluted EPS | 74.50% | 63.25% | 48.28% | 102.44% | 269.27% |
Average Basic Shares Outstanding | 0.61% | 0.63% | 0.65% | 0.60% | 0.54% |
Average Diluted Shares Outstanding | -0.12% | 0.02% | 0.15% | 0.39% | 0.62% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |